Document is current
Any future updates will be listed below
-
Authors
van Doorn-Schepens, M. L. M.
Abis, G. S. A.
Oosterling, S. J.
van Egmond, M.
Poort, L.
Stockmann, H. B. A. C.
Bonjer, H. J.
Savelkoul, P. H. M.
Budding, A. E.
-
Funding
Funding for this research was provided by:
Dutch Gastrointestinal and Liver Foundation
Spaarne Gasthuis Academy fund
- License Information
-
More Information
Article History
Received: 27 July 2021
Accepted: 22 December 2021
First Online: 1 October 2022
Declarations
:
: SELECT trial, registered at ClinicalTrials.gov, identifier: NCT01740947
: SELECT trial, registered at ClinicalTrials.gov, identifier: NCT01740947
: Not applicable.
: The sponsor of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript. Potential competing interest: AEB and PHS are involved in and co-founders of the IS-pro technology platform development. The other authors declare that no disclosures exist.
